Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure?

被引:29
作者
Zender, Niklas [1 ]
Weise, Felix K. [1 ]
Bordignon, Stefano [1 ]
Herrmann, Eva [2 ]
Konstantinou, Athanasios [1 ]
Bologna, Fabrizio [1 ]
Nagase, Takahiko [1 ]
Chen, Shaojie [1 ]
Chun, Kyoung Ryul Julian [1 ]
Schmidt, Boris [1 ]
机构
[1] Agaples Markus Krankenhaus, Cardioangiol Ctr Bethanien, Wilhelm Epstein Str 4, D-60431 Frankfurt, Germany
[2] Goethe Univ, Inst Biostat & Math Modelling, Dept Med, Frankfurt, Germany
来源
EUROPACE | 2019年 / 21卷 / 10期
关键词
Atrial fibrillation; Ablation; Left atrial appendage; Occlusion; Stroke; PULMONARY VEIN ISOLATION; OCCLUSION;
D O I
10.1093/europace/euz161
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Left atrial appendage electrical isolation (LAAI) may improve the rhythm outcome in selected patients with atrial fibrillation (AF). Controversy exists if LAAI is associated with an increased rate of thromboembolic complications. We sought to assess the feasibility, efficacy, and safety of interventional left atrial appendage closure (LAAC) in comparison to oral anticoagulation (OAC) after electrical LAAI. Methods and results Weeks after index LAAI using the cryoballoon or a linear maze like ablation strategy patients' left atrial appendage was invasively remapped. In case of persistent LAAI, LAAC was performed. Patients who refused invasive remapping continued OAC. The primary endpoint was composed of any stroke or systemic embolism (SE) and the occurrence of intracardiac thrombus. Secondary endpoints included stroke/SE, major bleeding, and all-cause death. Of 166 patients (51% female; mean age 70 +/- 8 years; mean CHAD(2)S(2)VASc score 3.4 +/- 1.8) after LAAI, 94 patients received LAAC (LAAC group) and 72 continued OAC (no LAAC). After LAAC, 83% of patients received dual antiplatelet therapy for 6weeks and aspirin thereafter. During a mean follow-up of 778 +/- 630 days, 5 and 11 primary endpoint events were observed in the LAAC and no LAAC group, respectively [hazard ratio (HR) 0.27, 95% confidence interval (CI) 0.10-0.75; P=0.010]. The calculated annual thromboembolic event rates were 6.9% (no LAAC) and 2.3% (LAAC), respectively. Left atrial appendage closure significantly reduced the incidence of stroke and SE (HR 0.31, CI 0.1-0.98; P=0.04). Conclusion After electrical LAAI for rhythm control in AF patients, interventional LAAC was associated with fewer thromboembolic complications when compared with OAC.
引用
收藏
页码:1502 / 1508
页数:7
相关论文
共 50 条
  • [41] Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation
    Fender, Erin A.
    Kiani, Jawad G.
    Holmes, David R., Jr.
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (11)
  • [42] The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives
    Wintgens, Lisette I. S.
    Maarse, Moniek
    Swaans, Martin J.
    Rensing, Benno J. W. M.
    Van Dijk, Vincent F.
    Boersma, Lucas V. A.
    EXPERT REVIEW OF MEDICAL DEVICES, 2020, 17 (07) : 615 - 625
  • [43] Left Atrial Appendage Closure in Atrial Fibrillation Patients with Cancer
    Zweiker, David
    Bergler-Klein, Jutta
    Fiedler, Lukas
    Toth, Gabor G.
    Achleitner, Reinhard
    Schratter, Alexandra
    Stix, Guenter
    Gabriel, Harald
    Binder, Ronald K.
    Rammer, Martin
    Pfeffer, Michael
    Vock, Paul
    Lileg, Brigitte
    Steinwender, Clemens
    Sihorsch, Kurt
    Hintringer, Florian
    Adukauskaite, Agne
    Martinek, Martin
    Sturmberger, Thomas
    Ablasser, Klemens
    Zirlik, Andreas
    Scherr, Daniel
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [44] A new frontier in left atrial appendage closure
    Narayanan, Arun
    Jneid, Hani
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 100 (05) : 929 - 930
  • [45] Antithrombotic Regimen After Percutaneous Left Atrial Appendage Closure
    Ryuzaki, Satoko
    Kondo, Yusuke
    Nakano, Miyo
    Nakano, Masahiro
    Kajiyama, Takatsugu
    Ito, Ryo
    Kitagawa, Mari
    Sugawara, Masafumi
    Chiba, Toshinori
    Yoshino, Yutaka
    Kobayashi, Yoshio
    CIRCULATION JOURNAL, 2023, 87 (12) : 1820 - +
  • [46] Left atrial appendage electrical isolation for persistent atrial fibrillation
    Madaffari, Antonio
    Grosse, Anett
    Conci, Elisabetta
    Geller, J. Christoph
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2019, 42 (03): : 306 - 308
  • [47] Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation
    Sawaya, Fadi
    Abi-Saleh, Bernard
    Hoteit, Abbas
    Jdaidany, Jennifer
    Moumneh, Mohamad B.
    Harbieh, Bernard
    Khoury, Maurice
    Aramouni, Salim
    Abdulhai, Farah
    Refaat, Marwan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [48] Clinical relevance of incomplete device endothelialization after left atrial appendage closure
    Xu, Jing
    Chen, Chuan Zhi
    Xing, Jun
    Wang, Liang
    Tao, Yi Rao
    Yang, Bing
    Zhang, Qi
    Shen, Yun Li
    Hu, Jian Qiang
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2023, 39 (02) : 451 - 459
  • [49] Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices
    Weise, Felix K.
    Bordignon, Stefano
    Perrotta, Laura
    Konstantinou, Athanasios
    Bologna, Fabrizio
    Nagase, Takahiko
    Chen, Shaojie
    Chun, Julian
    Schmidt, Boris
    EUROINTERVENTION, 2018, 13 (18) : E2138 - E2146
  • [50] Left atrial appendage electrical isolation and concomitant device occlusion: A safety and feasibility study with histologic characterization
    Panikker, Sandeep
    Virmani, Renu
    Sakakura, Kenichi
    Kolodgie, Frank
    Francis, Darrel P.
    Markides, Vias
    Walcott, Greg
    McElderry, H. Tom
    Wong, Tom
    HEART RHYTHM, 2015, 12 (01) : 202 - 210